Curcumin downregulates H19 gene transcription in tumor cells

Journal of Cellular Biochemistry

Volumn 104, Issue 5, 2008, Pages 1781-1792

  Kujundžić, Renata Novak ^a   Grbeša, Ivana ^a   Ivkić, Mirko ^b   Katdare, Meena ^c   Gall Trošelj, Koraljka ^a,c  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Curcumin; DNA topoisomerase II ; H19; Tumor cells

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); RNA POLYMERASE II; SOMATOMEDIN BINDING PROTEIN; TRANSCRIPTION FACTOR;

ALLELE; ARTICLE; BINDING SITE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL STRAIN HCT116; CHROMATIN; DOWN REGULATION; ENZYME SUBUNIT; GENETIC TRANSCRIPTION; GENOME; HELA CELL; HEP 2 CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL;

ALLELES; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; CYCLOOXYGENASE 2; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INSULIN-LIKE GROWTH FACTOR II; NAD; RNA, UNTRANSLATED; TRANSCRIPTION, GENETIC;

EID: 50249151314     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21742     Document Type: Article

References (58)

1. Aggarwal BB, Shishodia S. 2004. Suppression of the nuclear factor-kappaB activation pathway by spice- derived phytochemicals: Reasoning for seasoning. Ann NY Acad Sci 1030:434-441.
2. Aggarwal BB, Kumar A, Bharti AC. 2003. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 23:363-398.
3. Bartolomei MS, Tilghman SM. 1997. Genomic imprinting in mammals. Annu Rev Genet 31:493-525.
4. Basu GD, Tinder TL, Bradley JM, Tu T, Hattrup CL, Pockaj BA, Mukherjee P. 2006. Cycolooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: Role of IDO. J Immunol 177:2391-2401.
5. Belfi CA, Chatterjee S, Gosky DM, Berger SJ, Berger NA. 1999. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. Biochem Biophys Res Commun 257:361-368.
6. Bell AC, Felsenfeld G. 2000. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405:482-485.
7. Bernofsky C, Swan M. 1973. An improved cycling assay for nicotinamide adenine dinucleotide. Anal Biochem 53: 452-458.
8. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. 2000. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2:326-332.
9. Bhaumik S, Anjum R, Rangaraj N, Pardhasaradhi BW, Khar A. 1999. Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett 456:311-314.
10. Capranico G, Tinelli S, Austin CA, Fisher ML, Zunino F. 1992. Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development. Biochim Biophys Acta 1132:43-48.
11. Chernukin I, Shamsuddin S, Kang SY, Bergström R, Kwon Y-W, Yu WQ, Whitehead J, Mukhopadhyay R, Docquier F, Farrar D, Morrison I, Vigneron M, Wu SY, Chiang CM, Loukinov D, Lobanenkov V, Ohlsson R, Klenova E. 2007. CTCF interacts with and recruits the largest subunit of RNA polymerase II to CTCF target sites genome-wide. Mol Cell Biol 27:1631-1648.
12. Dingemans AM, Pinedo HM, Giaccone G. 1998. Clinical resistance to topoisomerase-targeted drugs. Biochim Biophys Acta 1400:275-288.
13. Faitova J, Krekac D, Hrstka R, Vojtesek B. 2006. Endoplasmis reticulum stress and apoptosis. Cell Mol Biol Lett 11:488-505.
14. Gosky D, Chatterjee S. 2003. Down-regulation of topoisomerase Hot is caused by up-regulation of G RP78. Biochem Biophys Res Commun 300:327-332.
15. Hadi SM, Asad SF, Singh S, Ahmad A. 2000. Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life 50:167-171.
16. Hark AT, Schoenherr C J, Katz D J, Ingram RS, Levorse JM, Tilghman SM. 2000. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405:486-489.
17. Holden JA, Perkins SL, Snow GW, Kjeldsberg CR. 1995. Immunohistochemical staining for DNA topoisomerase II in non-Hodkin's lymphomas. Am J Clin Pathol 104:54-59.
18. Jinno Y, Sengoku K, Nakao M, Tamate K, Miyamoto T, Matsuzaka T, Sutcliffe JS, Anan T, Takuma N, Nishiwaki K, Ikeda Y, Ishimaru T, Ishikawa M, Niikawa N. 1996. Mouse/human sequence divergence in a region with a paternal-specific methylation imprint at the human H19 locus. Hum Mol Genet 5:1155-1161.
19. Kaffer CR, Srivastava M, Park KY, Ives E, Hsieh S, Batlle J, Grinberg A, Huang SP, Pfeifer K. 2000. A transcriptional insulator at the imprinted H19/Igf2 locus. Genes Dev 14:1908-1919.
20. Kanduri C, Pant V, Loukinov D, Pugacheva E, Qi CF, Wolffe A, Ohlsson R, Lobanenkov W. 2000. Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr Biol 10:853-856.
21. Kim HT, Choi BH, Niikawa N, Lee TS, Chang SI. 1998. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors. Am J Med Genet 80:391-395.
22. Kim MS, Kang HJ, Moon A. 2001. Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cell. Arch Pharm Res 24:349-354.
23. Klenova E, Ohlsson R. 2005. Poly(ADP-ribosyl)ation and epigenetics: Is CTCF PARt of the plot? Cell Cycle 4: 96-101.
24. Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T, Takahashi T. 1995. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 10: 1193-1198.
25. Kroll DJ, Rowe TC. 1991. Phosphorylation of DNA topoisomerase II in human tumor cell line. J Biol Chem 266:7957-7961.
26. Laitusis AL, Brostrom MA, Brostrom CO. 1999. The dynamic role of GRP78/BiP in the coordination of mRNA translation with protein procesing. J Biol Chem 274:486-493.
27. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM. 1995. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375:34-39.
28. Leno GH, Ledford BE. 1990. Reversible ADP-ribosylation of the 78 kDa glucose-regulated protein. FEBS Lett 276: 29-33.
29. Manoharan H, Babcock K, Pitot HC. 2004. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene. Mol Carcinog 41:1-16.
30. Martin-Cordero C, Lopez-Lazaro M, Galvez M, Ayuso MJ. 2003. Curcumin as a DNA topoisomerase II poison. J Enzyme Inhib Med Chem 18:505-509.
31. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-Iail R, Hochberg A, Galun E. 2007. The H19 non-coding RNA is essential for human tumor growth. PLoS One 2:e845.
32. McLeod HL, Douglas F, Oates M, Symonds RP, Prakash D, Van Der Zee AGJ, Kaye SB, Brown R, Keith WN. 1994. Topoisomerase I and II activity in human breast, cervix, lung and colon cancer. Int J Cancer 59:607-611.
33. Mitchell LG, Bodenteich A, Merril CR. 1994. Use of silver staining to detect nucleic acids. In: Harwood AJ, editor. Methods in molecular biology: Protocol for gene analysis. Totowa: Humana Press. pp 197-203.
34. Mondal N, Parvin JD. 2001. DNA topoisomerase II α is required for RNA polymerase II transcription on chromatin templates. Nature 413:435-438.
35. Mukherjee Nee Chakraborty S, Ghosh U, Bhattacharyya NP, Bhattacharya RK, Dey S, Roy M, 2007. Curcumininduced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity. Mol Cell Biochem 297:31-39.
36. Munn DH. 2006. Indoleamine 2,3 dioxygenase, tumorinduced tolerance and counter-regulation. Curr Opin Immunol 18:220-225.
37. Paulson M, El-Maarri O, Engemann S, Strodike M, Franck O, Davies K, Reinhardt R, Reik W, Walter J. 2000. Sequence conservation and variability of imprinting in the Beckwith-Wiedemann syndrome gene cluster in human and mouse. Hum Mol Genet 9:1829-1841.
38. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. 1993. Relaxation of imprinted genes in human cancer. Nature 362:747-749.
39. Rainier S, Dobry CJ, Feinberg AP. 1995. Loss of imprinting in hepatoblastoma. Cancer Res 55:1836-1838.
40. Randhawa GS, Cui H, Barletta JA, Strichman-Almashanu LZ, Talpaz M, Kantarjian H, Deisseroth AB, Champlin RC, Feinberg AP. 1998. Loss of imprinting in disease progression in chronic myelogenous leukemia. Blood 91:3144-3147.
41. Rao CV. 2007. Regulation of COX and LOX by curcumin. Adv Exp Med Biol 595:213-226.
42. Ross W. 1985. DNA topoisomerases as targets for cancer therapy. Biochem Pharmacol 34:4191-4195.
43. Roth GN, Chandra A, Nair MG. 1998. Novel bioactivities of Curcuma longa constituents. J Nat Prod 61:542-545.
44. Roy M, Chakraborty S, Siddiqi M, Bhattacharya RK. 2002. Induction of apoptosis in tumor cells by natural phenolic compounds. Asian Pac J Cancer Prev 3:61-67.
45. Sambrook J, Fritsch EF, Maniatis T. 1989. Extraction with phenolxhloroform. In: Ford N, Nolan C, Ferguson M, editors. Molecular cloning: Laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. pp E.3-E.4.
46. Schutz G, Feigelson P. 1972. Purification and properties of rat liver tryptophan oxygenase. J Biol Chem 247:5327-5332.
47. Shen J, Chen X, Hendershot L, Prywes R. 2002. ER stress regulation of ATF6 localization by dissociation of BiP/ GRP78 binding and unmasking of Golgi localization signals. Dev Cell 3:99-111.
48. Shi Y, Vattem KM, Sood R, An J, Liang J, Stramm L, Wek RC. 1998. Identification and characterization of pancreatic eucaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control. Mol Cell Biol 18: 7499-7509.
49. Thorvaldsen JL, Duran KL, Bartolomei MS. 1998. Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev 12:3693-3702.
50. Tillman JB, Mote PL, Dhahbi JM, Walford RL, Spindler SR. 1996. Dietary energy restriction in mice negatively regulates hepatic glucose-regulated protein 78 (GRP78) expression at the posttranscriptional level. J Nutr 126: 416-423.
51. Ulaner GA, Yang Y, Hu J-F, Li T, Vu TH, Hoffman AR. 2003. CTCF binding at the Insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues. Endocrinology 144:4420-4426.
52. Vu TH, Li T, Nguyen D, Nguyen BT, Yao XM, Hu JF, Hoffman AR. 2000. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region. Genomics 64:132-143.
53. Wang JC. 1981. DNA topoisomerases. Annu Rev Biochem 50:879-910.
54. Ye J, Rawson RB, Komuro R, Chen X, Dave UP, Prywes R, Brown MS, Goldstein JL. 2000. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell 6:1355-1364.
55. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881-891.
56. Yoshida H, Matsui T, Hosokawa N, Kaufman RJ, Nagata K, Mori K. 2003. A time-dependent phase shift in the mammalian unfolded protein response. Dev Cell 4:265-271.
57. Zhang K, Kaufman RJ. 2006. The unfolded protein response: A stress signaling pathway critical for health and disease. Neurology 66:S102-S109.
58. Zhang Y, Shields T, Crenshaw T, Hao Y, Moulton T, Tycko B. 1993. Imprinting of human H19:allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am J Hum Genet 53:113-124.